IQVIA (IQV) is a publicly traded Healthcare sector company. As of August 19, 2026, IQV trades at $240.06 with a market cap of $39.71B and a P/E ratio of 29.88. IQV moved -0.50% today. Year to date, IQV is +6.49%; over the trailing twelve months it is +24.66%. Its 52-week range spans $134.65 to $251.36. Analyst consensus is strong buy with an average price target of $273.43. Rallies surfaces IQV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for IQV, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $240.06 |
| Market Cap | $39.71B |
| P/E Ratio | 29.88 |
| EPS | $8.12 |
| Dividend Yield | 0.00% |
| 52-Week High | $251.36 |
| 52-Week Low | $134.65 |
| Volume | 802.03K |
| Avg Volume | 0 |
| Revenue (TTM) | $16.98B |
| Net Income | $1.38B |
| Gross Margin | 0.00% |
16 analysts cover IQV: 0 strong buy, 15 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $273.43.